Bristol Myers Squibb positions India as a growth engine, investing in AI-led pharma commercialization, pipeline expansion, and faster market adoption across oncology and cardiology.
India pharma partnerships in 2025 are accelerating innovation, patient care, digital transformation, and market leadership through strategic alliances across R&D, tech, and supply chains.
Emcure Pharmaceuticals has announced a nationwide rollout of its obesity drug Poviztra, marking a focused push into India’s expanding weight-management market. The company plans to move beyond a metro-centric strategy and build demand across Tie...
Novartis is also rapidly increasing its business footprint in India making India its biggest global R&D center outside Switzerland. The Swiss firm has a workforce exceeding 9,000 employees in Hyderabad and Mumbai. This is a significant change...
.jpeg)
Akums launches an enhanced Gabapentin ER for postherpetic neuralgia, using sustained-release technology to improve pain control, once-daily dosing and patient adherence in India.
GSK Nucala has moved a step closer to European approval after the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended the drug for adults with uncontrolled COPD marked by raised blood eosinophils.
Pfizer’s HER2-targeted therapy TUKYSA delivered a strong boost in first-line maintenance treatment for HER2-positive metastatic breast cancer, marking a major advance in today’s data from the Phase 3 HER2CLIMB-05 trial.
.png)
Zydus Lifesciences Ltd. has launched Zyrifa, a 120 mg subcutaneous biosimilar of the monoclonal antibody Denosumab. The new product increases the number of cancer patients who can receive advanced treatment of bone-care which is cheape...
Novo Nordisk has officially closed its acquisition of Akero Therapeutics, marking a major move in the race to develop next-generation treatments for metabolic liver diseases. The deal, first announced on October 9, 2025, is now fully completed...
India’s rising weight burden is pushing healthcare forward, and Agilus Diagnostics is stepping in with a bold move. The company has rolled out its new obesity test suite, built to give clinicians deeper insight into insulin resistance, metabolic...
.jpg)
, CDSCO.jpg)